Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Cancer Res. 2018 May 14;78(13):3718–3730. doi: 10.1158/0008-5472.CAN-18-0306

Fig. 5. PI-3065/7DW8-5 liposomes are safe for repeated dosing.

Fig. 5

Representative hematoxylin and eosin-stained sections of several organs from controls or PI-3065/7DW8-5 liposome-treated animals (nine doses of 7×1013 empty control liposomes: 2 mg lipid; 3 doses × 3 weeks, or liposomes carrying 150 g PI-3065 and 10 µg 7DW8-5). Scale bars, 100 µm. Serum chemistry and blood counts for animals treated with PI-3065/7DW8-5 liposomes, or with phosphate-buffered saline as a control are shown on the right.